نتایج جستجو برای: cyp1a2

تعداد نتایج: 1781  

2011
Marilyn C. Cornelis Keri L. Monda Kai Yu Nina Paynter Elizabeth M. Azzato Siiri N. Bennett Sonja I. Berndt Eric Boerwinkle Stephen Chanock Nilanjan Chatterjee David Couper Gary Curhan Gerardo Heiss Frank B. Hu David J. Hunter Kevin Jacobs Majken K. Jensen Peter Kraft Maria Teresa Landi Jennifer A. Nettleton Mark P. Purdue Preetha Rajaraman Eric B. Rimm Lynda M. Rose Nathaniel Rothman Debra Silverman Rachael Stolzenberg-Solomon Amy Subar Meredith Yeager Daniel I. Chasman Rob M. van Dam Neil E. Caporaso

We report the first genome-wide association study of habitual caffeine intake. We included 47,341 individuals of European descent based on five population-based studies within the United States. In a meta-analysis adjusted for age, sex, smoking, and eigenvectors of population variation, two loci achieved genome-wide significance: 7p21 (P = 2.4 × 10(-19)), near AHR, and 15q24 (P = 5.2 × 10(-14))...

2018
Shijuan Xiong Lingling Li

This aim of the study was to investigate the effect of CYP1A2 gene polymorphism on the metabolism of theophylline in minority and Han nationality. A total of 50 cases of Han (Han group) and 50 minority nationalities (ethnic groups) treated with theophylline were selected for the study. The genotype and allele frequencies of the two groups of CYP1A2 gene, G-3113A and G-3860A, were compared to de...

2014
Jian Xiao Wei-Hua Huang Jing-Bo Peng Zhi-Rong Tan Dong-Sheng Ou-Yang Dong-Li Hu Wei Zhang Yao Chen

BACKGROUND Quercetin is abundant in plants and human diets. Previous studies indicated that quercetin inhibited the activity of CYP1A2, and the combination of quercetin with the substrates of CYP1A2 might produce herb-drug interactions. This research aims to determine the effects of quercetin and the CYP1A2 gene polymorphisms, namely, CYP1A2*1C  (-2964G>A) and *1F (734C>A), on the metabolism of...

Journal: :Journal of medical genetics 2004
M C Cornelis A El-Sohemy H Campos

BACKGROUND There is growing evidence that DNA damage caused by mutagens found in tobacco smoke may contribute to the development of coronary heart disease (CHD). In order to bind to DNA many mutagens require metabolic activation by cytochrome P450 (CYP) 1A1 or CYP1A2. The objective of this study was to determine the effects of CYP1A1 and CYP1A2 genotypes on risk of myocardial infarction (MI) an...

Journal: :British journal of clinical pharmacology 1995
L J Notarianni S E Oliver P Dobrocky P N Bennett B W Silverman

1. Caffeine is widely used as an in vivo probe for CYP1A2; the distribution/activity of this enzyme is reported to be reflected by metabolic ratios. 2. Several metabolic ratios using different combinations of urinary metabolites have been used to measure CYP1A2, with varying conclusions on its distribution. 3. A mathematical comparison of five metabolic ratios claiming to reflect CYP1A2 activit...

Journal: :British journal of pharmacology 2002
Nicholas E Hadjokas Renke Dai Fred K Friedman Michael J Spence Barry J Cusack Robert E Vestal Yongsheng Ma

1. Cytochrome P4501A2 (CYP1A2) activates a large number of procarcinogens to carcinogens. Phytochemicals such as flavones can inhibit CYP1A2 activity competitively, and hydroxylated derivatives of flavone (galangin) may be potent, selective inhibitors of CYP1A2 activity relative to CYP1A1 activity. Molecular modelling of the CYP1A2 interaction with hydroxylated derivatives of flavone suggests t...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007
Joanne Kotsopoulos Parviz Ghadirian Ahmed El-Sohemy Henry T Lynch Carrie Snyder Mary Daly Susan Domchek Susan Randall Beth Karlan Phil Zhang Shiyu Zhang Ping Sun Steven A Narod

We have recently reported that, among BRCA1 mutation carriers, the consumption of caffeinated coffee was associated with a significant reduction in breast cancer risk. Because the metabolism of caffeine is primarily by CYP1A2, we examined whether or not the CYP1A2 genotype modifies the association between a history of coffee consumption and the risk of breast cancer. A common A to C polymorphis...

2010
Kathrin Klein Stefan Winter Miia Turpeinen Matthias Schwab Ulrich M. Zanger

The human drug metabolizing cytochrome P450 (CYP) 1A2, is one of the major P450 isoforms contributing by about 5-20% to the hepatic P450 pool and catalyzing oxidative biotransformation of up to 10% of clinically relevant drugs including clozapine and caffeine. CYP1A2 activity is interindividually highly variable and although twin studies have suggested a high heritability, underlying genetic fa...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2007
Tatsuki Fukami Miki Nakajima Haruko Sakai Miki Katoh Tsuyoshi Yokoi

Human cytochrome CYP2A13 shows overlapping substrate specificity with CYP2A6, catalyzing the metabolism of coumarin, nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Recently, it was found that CYP2A13 could catalyze the metabolic activations of 4-aminobiphenyl and aflatoxin B(1), which are known to be catalyzed by human CYP1A2. In the present study, we investigated the s...

Journal: :Biochemical pharmacology 2008
Joshua E Muscat Brian Pittman Wayne Kleinman Philip Lazarus Steven D Stellman John P Richie

The lower incidence rate of transitional cell carcinoma of the urinary bladder in blacks than in whites may be due to racial differences in the catalytic activity of enzymes that metabolize carcinogenic arylamines in tobacco smoke. To examine this, we compared cytochrome P4501A2 (CYP1A2) and N-acetyltransferase-2 activities (NAT2) in black and white smokers using urinary caffeine metabolites as...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید